Search images on Google Product Monograph
Active Ingredients:
- bortezomib (bortezomib mannitol boronic ester), 3.5 MG/VIAL
DIN: 02438399
Dosage Form(s): POWDER FOR SOLUTION
Route(s) of Administration: INTRAVENOUS, SUBCUTANEOUS
Description: SINGLE-USE VIAL
Schedule: Prescription
Company: TEVA CANADA LIMITED – official site
ATC:
- L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
- L01X - OTHER ANTINEOPLASTIC AGENTS (ATC, WHO)
- L01XG - (ATC, WHO)
- L01XG01 - BORTEZOMIB (WHO)
External Links for Act Bortezomib:
Search on Google
Teva Canada Limited
Go to Teva website to see drug product details. Sometimes you can find act bortezomib photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.